The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report
Open accessAbstract
BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS: We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS: Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS: These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites
Bausch, D. G., Towner, J. S., Dowell, S. F., Kaducu, F., Lukwiya, M., Sanchez, A., Nichol, S. T., Ksiazek, T. G., & Rollin, P. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/520545 · Cited by 522
Self-citationTowner, J. S., Rollin, P. E., Bausch, D. G., Sanchez, A., Crary, S. M., Vincent, M., Lee, W. F., Spiropoulou, C. F., Ksiazek, T. G., Lukwiya, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4330-4341.2004 · Cited by 515
Self-citationPsychosocial effects of an Ebola outbreak at individual, community and international levels
Van Bortel, T., Basnayake, A., Wurie, F., Jambai, M., Koroma, A. S., Muana, A. T., Hann, K., Eaton, J., Martin, S., & Nellums, L. B. (2016) · Bulletin of the World Health Organization · doi:10.2471/blt.15.158543 · Cited by 471
Dowell, S. F., Mukunu, R., Ksiazek, T. G., Khan, A. S., Rollin, P. E., Peters, C. J., & the Commission de Lutte contre les Epidémies à Kikwit (1999) · The Journal of Infectious Diseases · doi:10.1086/514284 · Cited by 398
Rowe, A. K., Bertolli, J., Khan, A. S., Mukunu, R., Muyembe‐Tamfum, J. J., Bressler, D., Williams, A. J., Peters, C. J., Rodriguez, L., Feldmann, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514318 · Cited by 387
Self-citationA case of Ebola virus infection.
Emond, R. T., Evans, B., Bowen, E. T., & Lloyd, G. (1977) · BMJ · doi:10.1136/bmj.2.6086.541 · Cited by 353
Rodriguez, L. L., De Roo, A., Guimard, Y., Trappier, S. G., Sanchez, A., Bressler, D., Williams, A. J., Rowe, A. K., Bertolli, J., Khan, A. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514291 · Cited by 311
Self-citationDiallo, B., Sissoko, D., Loman, N. J., Bah, H. A., Bah, H., Worrell, M. C., Conde, L. S., Sacko, R., Mesfin, S., Loua, A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw601 · Cited by 263
Self-citationPossible sexual transmission of Ebola virus - Liberia, 2015.
Christie, A., Davies-Wayne, G., Cordier-Lassalle, T., Cordier-Lasalle, T., Blackley, D. J., Laney, A. S., Williams, D. E., Shinde, S. A., Badio, M., Lo, T., et al. (2015) · PubMed Central · Cited by 176
Sissoko, D., Duraffour, S., Kerber, R., Kolié, J. S., Béavogui, A. H., Camara, A.-M., Colin, G., Rieger, T., Oestereich, L., Pályi, B., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30243-1 · Cited by 127
Self-citation
Cited by
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Self-citationLee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
Lazear, H. M., & Diamond, M. S. (2016) · Journal of Virology · doi:10.1128/jvi.00252-16 · Cited by 455
Malvy, D., McElroy, A. K., de Clerck, H., Günther, S., & van Griensven, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33132-5 · Cited by 419
The Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100506 · Cited by 404
Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?
Mansuy, J. M., Dutertre, M., Mengelle, C., Fourcade, C., Marchou, B., Delobel, P., Izopet, J., & Martin-Blondel, G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00138-9 · Cited by 384
Late Ebola virus relapse causing meningoencephalitis: a case report
Jacobs, M., Rodger, A., Bell, D. J., Bhagani, S., Cropley, I., Filipe, A., Gifford, R. J., Hopkins, S., Hughes, J., Jabeen, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30386-5 · Cited by 361
Milligan, I. D., Gibani, M. M., Sewell, R., Clutterbuck, E. A., Campbell, D., Plested, E., Nuthall, E., Voysey, M., Silva-Reyes, L., McElrath, M. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.4218 · Cited by 324
A gendered human rights analysis of Ebola and Zika: locating gender in global health emergencies
DAVIES, S. E., & BENNETT, B. (2016) · International Affairs · doi:10.1111/1468-2346.12704 · Cited by 317
The evolution of Ebola virus: Insights from the 2013-2016 epidemic
Holmes, E. C., Dudas, G., Rambaut, A., & Andersen, K. G. (2016) · Nature · doi:10.1038/nature19790 · Cited by 314
Baang, J. H., Smith, C., Mirabelli, C., Valesano, A. L., Manthei, D. M., Bachman, M. A., Wobus, C. E., Adams, M., Washer, L., Martin, E. T., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa666 · Cited by 307
Diallo, B., Sissoko, D., Loman, N. J., Bah, H. A., Bah, H., Worrell, M. C., Conde, L. S., Sacko, R., Mesfin, S., Loua, A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw601 · Cited by 263
Self-citationJames, P. B., Wardle, J., Steel, A., & Adams, J. (2020) · BMC Public Health · doi:10.1186/s12889-020-8279-7 · Cited by 72
“Such fear is profound if EVD survivors experience post-Ebola sequelae [12, 13] or are aware that the Ebola virus can be present in certain immune-protective parts of the body after convalescence (for example, the semen, breast milk, ocular (eye) fluid, and spinal column fluid) [14, 15] .”
Background
Metadata
- Authors
- Deen, G. F., Broutet, N., Xu, W., Knust, B., Sesay, F. R., McDonald, S. L. R., Ervin, E., Marrinan, J. E., Gaillard, P., Habib, N., Liu, H., Liu, W., Thorson, A. E., Yamba, F., Massaquoi, T. A., James, F., Ariyarajah, A., Ross, C., Bernstein, K., Coursier, A., Klena, J., Carino, M., Wurie, A. H., Zhang, Y., Dumbuya, M. S., Abad, N., Idriss, B., Wi, T., Bennett, S. D., Davies, T., Ebrahim, F. K., Meites, E., Naidoo, D., Smith, S. J., Ongpin, P., Malik, T., Banerjee, A., Erickson, B. R., Liu, Y., Liu, Y., Xu, K., Brault, A., Durski, K. N., Winter, J., Sealy, T., Nichol, S. T., Lamunu, M., Bangura, J., Landoulsi, S., Jambai, A., Morgan, O., Wu, G., Liang, M., Su, Q., Lan, Y., Hao, Y., Formenty, P., Ströher, U., & Sahr, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-10-12
- Volume
- 377
- Issue
- 15
- Pages
- 1428-1437
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2326558924
- Cited by
- 375
- References
- 19
- FWCI
- 37.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.